Skip to main content

Wacker expanding on multiple fronts

Wacker Chemie has announced plans to invest “a double-digit million euro amount” on it the new Biotechnology Centre at its corporate research facility in Munich, which is due to be operational in 2024. CEO Christian Hartel said that building it “will allow us to concentrate and intensify our research activities in the area of biotechnology. The additional capacity we will create here will accelerate the growth of our life-sciences division.”

Subscribe to Halle